Search

You searched for "Drooling"

1315 results found

BRS Juniors Day 2025

22 May 2025 | ENTA - ENT, ENTA - Rhinology / Sinus
OCH AYE, THE BRS JUNIORS! A special update from the BRS Juniors Committee Joshua Michaels, ENT ST6, BRS Juniors Committee Member 2024/25 With a successful year of research, development and education delivered by the BRS Juniors' Committee, we had the...
Audiology and Neurotology journal cover image

Quality of life after cochlear implantation in the older population

1 July 2021 | | ENTA - Audiology - Auditory Implants, ENTA - Neurotology
Cochlear implants (CI) have been increasingly adopted in older adults with severe to profound hearing loss as a result of the growing and ageing world population. There is much interest in the cost-effectiveness and quality of life in CI users....

Effect of COVID-19 on hearing and balance

5 January 2022 | | ENTA - Neurotology, ENTA - Vestibular Disorders
Rhinological symptoms are cardinal features of COVID-19. However there have only been anecdotal reports on the involvement of the ear, the closest neighbour to the nose and throat. The aim of this study was ‘to assess the presence of persistent...

Audeara personalised headphones win Innovator Award

19 November 2021 | Awards, Conferences & Anniversaries, Company Profiles, Research & Development
Audeara Ltd is a hearing health technology company delivering high-quality personalised audio to listeners.

Neuromod launches Ótologie specialist tinnitus care service

12 January 2022 | Company Profiles, Contracts & Distributors, Research & Development
Medical device company, Neuromod Devices Ltd, has launched a specialist tinnitus care service, Ótologie.

William Demant Foundation Donates DKK 8 Million ($1.2 Million USD) for Humanitarian Aid Inside and Outside Ukraine

23 March 2022 | Company Profiles, Global Health
The William Demant Foundation has announced plans to donate DKK 8 million ($1.2 million USD) to support humanitarian aid in and outside Ukraine to meet the growing needs of children and families, including those on the move.

Karl Strom Joins HearingTracker as Editor in Chief

19 May 2022 | Company Profiles, Recruitment & Personnel
HearingTracker has appointed Karl Strom as its new Editor in Chief.

GSI releases video series: Closing the Audiology Gap with Automation

2 August 2022 | Research & Development
Grason-Stadler, a worldwide leader of clinical audiometric systems, hosted a conversation with Dr James W Hall III and Dr Robert Margolis to discuss the current landscape around the patient-provider gap and the essential need for an automated tool.

Enhancing surgical outcomes in TOETVA – with neuromonitoring essentials by Langer Medical

10 September 2024 | Research & Development
Intraoperative neuromonitoring has become a standard practice in all thyroid surgery, allowing for the precise localisation and reliable monitoring of neurophysiological structures at-risk.

VARTA Showcases Comprehensive, Sustainable Battery Range at EUHA 2025

7 November 2025 | Company Profiles, Awards, Conferences & Anniversaries
VARTA AG presented its comprehensive range of energy solutions for the medical hearing sector at EUHA 2025 last week, the world’s largest trade event for the hearing aid industry. Operating under the motto "Empower Your Hearing", the company showcased its...

In conversation with Professor Charles Liberman

1 January 2019 | | ENTA - Audiology - Adult, ENTA - Tinnitus
Just before I left Cambridge to work with the Hearing Sciences group in Nottingham, I spent a very happy hour alone in the company of Professor Charles Liberman, the Director of the Eaton-Peabody Laboratories based at the Massachusetts Eye and...

Triple semicircular canal occlusion and Meniere’s disease: a rising alternative treatment?

7 January 2021 | | ENTA - Head & Neck, ENTA - Otology, ENTA - Vestibular Disorders
Patients with dizziness form a large part of the workload for ENT surgeons. In the overwhelming majority of cases, management will be medical and successful. However, occasionally some patients present a challenge when they have not responded to conventional treatments....